Research Overview: Follistatin 344 Peptide
Follistatin 344 is a myostatin inhibitor peptide that researchers study for its role in muscle development and growth factor regulation. This Sterling Knight formulation provides 2mg of research-grade peptide for in-vitro laboratory investigations. Researchers at Stroid UK Shop choose this compound to examine myostatin signalling pathways and their effects on muscle fibre development. The peptide belongs to the follistatin protein family, which naturally occurs in mammals and regulates various growth factors including activin and myostatin.
Laboratory Research Applications
Scientists investigate Follistatin 344 for its potential in muscle wasting studies and myostatin research protocols. This peptide enables researchers to examine how myostatin inhibition affects muscle protein synthesis and cellular proliferation. Laboratory studies focus on understanding the molecular mechanisms behind muscle growth regulation and how follistatin proteins interact with transforming growth factor-beta superfamily members. Researchers studying peptides often combine this compound with other growth factors to evaluate synergistic effects. The 344 amino acid sequence provides optimal stability for extended research protocols, making it valuable for longitudinal studies examining muscle development pathways.
Technical Specifications
| Parameter | Specification |
|---|---|
| Molecular Weight | Verify with supplier |
| Sequence Length | 344 amino acids |
| Purity | ≥98% (HPLC verified) |
| Formulation | Lyophilised powder |
| Storage | -20°C, desiccated |
| Reconstitution | Sterile bacteriostatic water |
| CAS Number | Verify with supplier |
| Manufacturer | Sterling Knight |
Researchers studying muscle biology often investigate this peptide alongside compounds from our SARMs collection to understand different muscle development mechanisms. The Sterling Knight manufacturing ensures consistent quality for reproducible research outcomes.
Research Compliance Information
This Follistatin 344 2mg Sterling Knight product is manufactured exclusively for in-vitro research applications and laboratory studies. It is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must handle this compound according to proper laboratory safety protocols and local regulations governing peptide research. All studies should be conducted by qualified personnel in appropriate research facilities with proper biosafety measures.
